Description
Phezam is combined medicinal product containing the active substances piracetam and cinnarizine. The combined product has a pronounced antihypoxic effect. The two active substances are mutually potentiated in relation to the reduction of cerebrovascular resistance. The combination increases cerebral blood flow. Piracetam belongs to the group of so-called nootropic pharmaceuticals improving and restoring cognitive processes and mental capacity.
Cinnarizine is a selective blocker, suppressing calcium ion transport processes through cell membranes and leads to dilation of the blood vessels, reduces the excitability of the vestibular center, increases the resistance of the cells to oxygen insufficiency.
